FAM114A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.051800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.109400E-01
Normal-vs-Stage2
2.631000E-01
Normal-vs-Stage3
7.326600E-01
Normal-vs-Stage4
2.210800E-01
Stage1-vs-Stage2
7.024800E-01
Stage1-vs-Stage3
7.004400E-01
Stage1-vs-Stage4
4.306600E-01
Stage2-vs-Stage3
4.073800E-01
Stage2-vs-Stage4
3.967200E-01
Stage3-vs-Stage4
2.817000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.163400E-01
Normal-vs-AfricanAmerican
1.903160E-01
Normal-vs-Asian
4.778000E-01
Caucasian-vs-AfricanAmerican
5.200800E-01
Caucasian-vs-Asian
7.221800E-01
AfricanAmerican-vs-Asian
4.548000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.174000E-01
Normal-vs-Female
2.950800E-01
Male-vs-Female
3.838200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.863400E-01
Normal-vs-Age(41-60Yrs)
1.230980E-01
Normal-vs-Age(61-80Yrs)
3.858200E-01
Normal-vs-Age(81-100Yrs)
6.504800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.645820E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.701400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.346400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.117600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.010020E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.569200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.856800E-01
Normal-vs-Daily Drinker
7.200600E-01
Normal-vs-Weekly Drinker
2.242400E-01
Normal-vs-Occasional Drinker
2.983000E-01
Normal-vs-Social Drinker
2.103600E-01
Non Drinker-vs-Daily Drinker
1.780440E-01
Non Drinker-vs-Weekly Drinker
2.961600E-01
Non Drinker-vs-Occasional Drinker
4.542200E-01
Non Drinker-vs-Social Drinker
2.668200E-01
Daily Drinker-vs-Weekly Drinker
3.213700E-02
Daily Drinker-vs-Occasional Drinker
6.440400E-02
Daily Drinker-vs-Social Drinker
2.611800E-02
Weekly Drinker-vs-Occasional Drinker
7.817600E-01
Weekly Drinker-vs-Social Drinker
9.747800E-01
Occasional Drinker-vs-Social Drinker
7.515000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.946800E-01
Normal-vs-Grade 2
5.026400E-01
Normal-vs-Grade 3
5.070400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.233600E-01
Grade 1-vs-Grade 3
1.561820E-01
Grade 1-vs-Grade 4
8.946800E-01
Grade 2-vs-Grade 3
6.943200E-01
Grade 2-vs-Grade 4
5.026400E-01
Grade 3-vs-Grade 4
5.070400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.468600E-01
Normal-vs-NonDiabetic
3.405000E-01
Diabetic-vs-NonDiabetic
7.952600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.255800E-02
Normal-vs-NoPancreatitis
3.464200E-01
Pancreatitis-vs-NoPancreatitis
2.972800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.946400E-01
Normal-vs-N1
2.630600E-01
N0-vs-N1
4.960000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.717400E-01
Normal-vs-TP53-NonMutant
4.629800E-01
TP53-Mutant-vs-TP53-NonMutant
7.864300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
